2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
Interest Income | 236,165 | -5.707% | 250,458 | 269,629 | 304,952 | 320,349 |
Interest Expense | (49,016) | -5.961% | (52,123) | (51,751) | (48,978) | (49,553) |
Net Interest Income | 187,149 | -5.640% | 198,335 | 217,878 | 255,974 | 270,796 |
Other Operating Income | (12,677) | -- | 9,930 | 34,066 | 7,681 | 14,172 |
Total Operating Income | 174,472 | -16.226% | 208,265 | 251,944 | 263,655 | 284,968 |
Net Insurance Claims Incurred & Movement in Policyholders' Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
Net Operating Income | 174,472 | -16.226% | 208,265 | 251,944 | 263,655 | 284,968 |
Operating Expenses | (52,881) | -1.002% | (53,416) | (57,658) | (52,750) | (59,761) |
Impairment Losses on Loans & Advances | 7,836 | -- | (17,835) | (18,877) | (43,992) | (34,252) |
Other Impairment Losses | 1,664 | -- | (4,419) | (2,246) | (4,841) | (2,473) |
Operating Profit / (Loss) | 131,091 | -1.134% | 132,595 | 173,163 | 162,072 | 188,482 |
Change in FV & Impairment on Inv. Prop. | 0 | -- | 0 | 0 | 0 | 0 |
Change in FV & Impairment on Others | 0 | -- | 0 | 0 | 0 | 0 |
Profit / (Loss) on Disposal | 0 | -- | 0 | 0 | 0 | 0 |
Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 |
Profit / (Loss) before Taxation | 131,091 | -1.134% | 132,595 | 173,163 | 162,072 | 188,482 |
Taxation | (34,455) | -4.022% | (35,899) | (45,465) | (44,249) | (47,694) |
Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | (3,986) | 18.772% | (3,356) | (11,209) | (7,579) | (9,201) |
Others | -- | -- | -- | -- | -- | -- |
Profit / (Loss) Attributable to Shareholders | 92,650 | -0.739% | 93,340 | 116,489 | 110,244 | 131,587 |
2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
Depreciation & Amortisation | 6,276 | -22.814% | 8,131 | 8,249 | 7,884 | 8,608 |
Directors' Emoluments | -- | -- | -- | -- | -- | -- |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
EPS (cts) | 8.000 | 0.000% | 8.000 | 10.000 | 9.000 | 11.000 |
DPS (cts) | 2.000 | -- | 4.000 | 5.000 | 0.000 | 0.000 |
Dividend Payout Ratio (%) | 25.000% | -- | 50.000% | 50.000% | -- | -- |
Cash flow per share ($) | 0.241 | -- | (0.005) | 0.060 | 0.126 | 0.079 |
NBV per share ($) | 1.648 | -- | 1.609 | 1.580 | 1.481 | 1.387 |
Remarks: | Real time quote last updated: 28/11/2024 17:59 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders (¥) | RMB 44,940,000 |
%Change | -19.826% |
EPS / (LPS) | RMB 0.040 |
NBV Per Share (¥) | RMB 1.666 |